Clinical Trials Browser

INDUSTRY × Interventional × KRN-330 × Clear all

Colorectal Neoplasms

NCT00838578 2024-04-26

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Clinical Trials

Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer